Skip to main content
Premium Trial:

Request an Annual Quote

Karin Remington, Greg Calaman, Christopher Thomajan

Premium
The National Institute of General Medical Sciences has appointed Karin Remington as director of the Center for Bioinformatics and Computational Biology. Remington will oversee more than 1,300 research and training grants totaling about $89 million to support bioinformatics and computational biology projects, including the National Centers for Biomedical Computing initiative.
 
CBCB also oversees NIH's Biomedical Information Science and Technology Initiative and partners with the National Science Foundation to support research and training in mathematical biology.
 
Remington most recently served as the project manager for the National Ecological Observatory Network. Prior to that, she was vice president of bioinformatics research at the J. Craig Venter Institute from 2002 to 2006. She worked at Celera Genomics from 1999 to 2002, where she developed mathematical methods for analyzing the fruit fly, human, and mouse genomes.
 

 
Definiens has appointed Greg Calaman as vice president of its North American operations. Calaman joined the company from Pfizer, where he was part of the company’s worldwide IT leadership team. Prior to Pfizer, Calaman led the professional services organization at BEA Systems, and founded iArmor, a technology company that specialized in the cardiovascular outpatient market.
 

 
Genstruct has hired Christopher Thomajan as chief financial officer. Thomajan previously served as CFO at Impress Software, Delphi Internet Services, Asurion, Celadon Science, and American’s Growth Capital. Prior to joining Genstruct.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.